List of Ambrx patents

Patents where

Current Assignee

Name

Ambrx

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11420999 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives	Patent 11420999 was granted and assigned to Ambrx on August, 2022 by the United States Patent and Trademark Office.	Ambrx	Ambrx	United States Patent and Trademark Office	11420999	August 23, 2022
‌ US Patent 7385028 Derivatization of non-natural amino acids and polypeptides	Patent 7385028 was granted and assigned to Ambrx on June, 2008 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	7385028	June 10, 2008
‌ US Patent 7332571 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides	Patent 7332571 was granted and assigned to Ambrx on February, 2008 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	7332571	February 19, 2008
‌ US Patent 9586988 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides	Patent 9586988 was granted and assigned to Ambrx on March, 2017 by the United States Patent and Trademark Office.	Ambrx	Ambrx	United States Patent and Trademark Office	9586988	March 7, 2017
‌ US Patent 7638491 Therapies using non-natural amino acids and polypeptides	Patent 7638491 was granted and assigned to Ambrx on December, 2009 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	7638491	December 29, 2009
‌ US Patent 9133495 Hybrid suppressor tRNA for vertebrate cells	Patent 9133495 was granted and assigned to Ambrx on September, 2015 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	9133495	September 15, 2015
‌ US Patent 7230068 Polymer derivatives	Patent 7230068 was granted and assigned to Ambrx on June, 2007 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	7230068	June 12, 2007
‌ US Patent 8420792 Suppressor tRNA transcription in vertebrate cells	Patent 8420792 was granted and assigned to Ambrx on April, 2013 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	8420792	April 16, 2013
‌ US Patent 8735539 Relaxin polypeptides comprising non-naturally encoded amino acids	Patent 8735539 was granted and assigned to Ambrx on May, 2014 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	8735539	May 27, 2014
‌ US Patent 11459392 Anti-CD70 antibody drug conjugates		Ambrx	Ambrx	United States Patent and Trademark Office	11459392	October 4, 2022
‌ US Patent 11311605 Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptides	Patent 11311605 was granted and assigned to Ambrx on April, 2022 by the United States Patent and Trademark Office.	Ambrx	Ambrx	United States Patent and Trademark Office	11311605	April 26, 2022
‌ US Patent 7846689 Compositions of aminoacyl-tRNA synthetase and uses thereof	Patent 7846689 was granted and assigned to Ambrx on December, 2010 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	7846689	December 7, 2010
‌ US Patent 7858344 Compositions of aminoacyl-tRNA synthetase and uses thereof	Patent 7858344 was granted and assigned to Ambrx on December, 2010 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	7858344	December 28, 2010
‌ US Patent 7838265 Compositions of aminoacyl-tRNA synthetase and uses thereof	Patent 7838265 was granted and assigned to Ambrx on November, 2010 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	7838265	November 23, 2010
‌ US Patent 7736872 Compositions of aminoacyl-TRNA synthetase and uses thereof	Patent 7736872 was granted and assigned to Ambrx on June, 2010 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	7736872	June 15, 2010
‌ US Patent 7829310 Compositions of aminoacyl-tRNA synthetase and uses thereof	Patent 7829310 was granted and assigned to Ambrx on November, 2010 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	7829310	November 9, 2010
‌ US Patent 7632823 Compositions of tRNA and uses thereof	Patent 7632823 was granted and assigned to Ambrx on December, 2009 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	7632823	December 15, 2009
‌ US Patent 7883866 Compositions of aminoacyl-tRNA synthetase and uses thereof	Patent 7883866 was granted and assigned to Ambrx on February, 2011 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	7883866	February 8, 2011
‌ US Patent 7632924 Antigen-binding polypeptides and their uses	Patent 7632924 was granted and assigned to Ambrx on December, 2009 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	7632924	December 15, 2009
‌ US Patent 7638299 Biosynthetic polypeptides utilizing non-naturally encoded amino acids	Patent 7638299 was granted and assigned to Ambrx on December, 2009 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	7638299	December 29, 2009
‌ US Patent 8178494 Modified human growth hormone formulations with an increased serum half-life	Patent 8178494 was granted and assigned to Ambrx on May, 2012 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	8178494	May 15, 2012
‌ US Patent 10954270 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives	Patent 10954270 was granted and assigned to Ambrx on March, 2021 by the United States Patent and Trademark Office.	Ambrx	Ambrx	United States Patent and Trademark Office	10954270	March 23, 2021
‌ US Patent 8383365 Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives	Patent 8383365 was granted and assigned to Ambrx on February, 2013 by the United States Patent and Trademark Office.		Ambrx	United States Patent and Trademark Office	8383365	February 26, 2013
‌ US Patent 9452222 Nucleic acids encoding modified relaxin polypeptides	Patent 9452222 was granted and assigned to Ambrx on September, 2016 by the United States Patent and Trademark Office.	Ambrx	Ambrx	United States Patent and Trademark Office	9452222	September 27, 2016
‌ US Patent 9975936 Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acids	Patent 9975936 was granted and assigned to Ambrx on May, 2018 by the United States Patent and Trademark Office.	Ambrx	Ambrx	United States Patent and Trademark Office	9975936	May 22, 2018

Results per page:

94 results

0 selected

94 results

0 selected